Effect of ADRB2 polymorphisms on response to longacting β2 -agonist therapy: a pharmacogenetic analysis of two randomised studies
The Lancet (British edition), 2007-12, Vol.370 (9605), p.2118-2125 [Peer Reviewed Journal]Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(07)61906-0
Full text available